Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02702999 · ClinicalTrials.gov registry record · NA
Determination of Abnormal Fetal Growth or Amniotic Fluid With Third Trimester Ultrasounds in Uncomplicated Pregnancies: A Randomized Trial
A NA study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- NA
- Development phase
- 206
- Enrollment target
NCT02702999 is a NA study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 206 participants.
The verdict
NCT02702999, a NA study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 206 participants
- Enrollment target
Study Summary
The purpose of this study is to see whether women at a gestational age of 30 weeks or more without comorbidities, does performance of serial 3rd trimester growth ultrasounds increase the frequency of identifying abnormalities in fetal growth or amniotic fluid, when compared with women who only receive indicated ultrasounds?
Interventions
- DEVICE Clinically-indicated ultrasound
- DEVICE Serial third trimester ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 206 participants |
| Start Date | 2016-06 |
| Est. Completion | 2017-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02702999
The ClinicalTrials.gov registry entry for NCT02702999 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 206 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Clinically-indicated ultrasound is the first listed.
NCT02702999 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02702999 about?
NCT02702999 is a clinical study titled "Determination of Abnormal Fetal Growth or Amniotic Fluid With Third Trimester Ultrasounds in Uncomplicated Pregnancies: A Randomized Trial". The purpose of this study is to see whether women at a gestational age of 30 weeks or more without comorbidities, does performance of serial 3rd trimester growth ultrasounds increase the frequency of identifying abnormalities in fetal growth or amniotic fluid, when compared with women who only recei...
What is the current status of trial NCT02702999?
This trial is currently completed. It is a NA study. The enrollment target is 206 participants. The study started on 2016-06. Estimated completion is 2017-08.
What interventions are being tested in trial NCT02702999?
The interventions under investigation include: Clinically-indicated ultrasound (DEVICE), Serial third trimester ultrasound (DEVICE).
Who is sponsoring clinical trial NCT02702999?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.